Cardiac Rhythm Management Devices | Market Insights | Europe (Supplemental) | 2023
The global COVID-19 pandemic had a negative impact on European CRM procedure volumes and market growth in 2020; however, following a period of recovery, the European CRM device market will grow modestly through 2031. Growth in market revenue will be driven by increasing adoption of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs. However, increasing competition in the leadless pacemaker and S-ICD markets will put downward pressure on prices and consequently limit growth to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2031.